H006629, H006629, H006629, LEVODOPA AND DECARBOXYLASE INHIBITOR , H006629
ZB203L01
Phase 3 small_molecule active
Quick answer
H006629, H006629, H006629, LEVODOPA AND DECARBOXYLASE INHIBITOR , H006629 for Motor fluctuations in advanced Parkinson’s disease is a Phase 3 program (small_molecule) at Zambon SpA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zambon SpA
- Indication
- Motor fluctuations in advanced Parkinson’s disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active